News dalla letteratura

	Hypersensitivity reactions to proton-pump inhibitors: Clinical presentation, diagnosis, and management Allergy Asthma Proc. 2020 Mar 1;41(2):e37-e44
	Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial Lancet Respir Med 2021 Apr 9;S2213-2600(21)00160-0
	Severe asthma management in the era of biologics: insights of the Italian Registry on Severe Asthma (IRSA) Eur Ann Allergy Clin Immunol Vol 53, N.3, 103-114, 2021
	The severe asthma registries: a way to better know and fight the disease Eur Ann Allergy Clin Immunol Vol 53, N.3, 99-102, 2021
	Triple vs Dual Inhaler Therapy and Asthma Outcomes in Moderate to Severe Asthma A Systematic Review and Meta-analysis JAMA 2021
	Esiti dell'asma infantile durante la pandemia COVID-19: risultati della coorte multinazionale PeARL. Allergy 2021 Feb 20
	Global absence and targeting of protective immune states in severe COVID-19 Nature 23 ottobre 2020
	Higher airborne pollen concentrations correlated with increased SARS-CoV-2 infection rates, as evidenced from 31 countries across the globe PNAS March 2021 Vol. 118 No. 12
	SARS-CoV-2, COVID-19, skin and immunology – What do we know so far? Allergy. March 2021;76:698–713.
	ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines - an EAACI-ARIA position paper Allergy. 2020 Dec 30

12 3 4 5 6

Pagina 1 di 6